Analyst Ranking
Bottom 4%
#4701 out of 4868 analysts
Average Return
-4.75%
Win Rate
42%69 out of 164
Risk vs Reward
Poor
Good

Matthew O'Brien's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Miromatrix Medical IncMIRO
+202.68%$1.12$3.39
2023-05-12 -
2023-12-12
Strong Buy
Cutera IncCUTRQ
+139.30%$11.78$28.19
2020-04-22 -
2021-04-22
Strong Buy
Abiomed IncABMD
+127.99%$125.54$286.22
2017-04-06 -
2018-04-06
Strong Buy
Miromatrix Medical IncMIRO
+115.92%$1.57$3.39
2023-04-03 -
2023-12-12
Strong Buy
Tandem Diabetes Care IncTNDM
+109.93%$15.20$31.91
2023-11-02 -
2024-11-01
Strong Buy

Matthew O'Brien Analyst Color

Get additional color on Matthew O'Brien's coverage of popular stocks

Matthew O'Brien's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Transmedics Group IncTMDX
10Strong Buy$105.00+14.12%Reiterates
3 days ago
Glaukos CorpGKOS
9Strong Buy$165.00+75.07%Maintains
17 days ago
Kestra Medical Technologies LtdKMTS
1Strong Buy$27.00+12.22%Initiates Coverage On
a month ago
Tela Bio IncTELA
6Hold$2.00+106.19%Downgrades
a month ago
Sight Sciences IncSGHT
7Hold$3.50+14.75%Maintains
2 months ago
Teleflex IncTFX
4Hold$140.00+2.15%Downgrades
2 months ago
Alphatec Holdings IncATEC
4Strong Buy$13.00+18.40%Maintains
2 months ago
Beta Bionics IncBBNX
1Strong Buy$26.00+135.29%Initiates Coverage On
2 months ago
Insulet CorpPODD
9Strong Buy$310.00+22.87%Maintains
2 months ago
Penumbra IncPEN
13Strong Buy$330.00+12.69%Reiterates
2 months ago
Atricure IncATRC
3Strong Buy$50.00+67.17%Maintains
3 months ago
Staar Surgical CoSTAA
7Hold$16.00-12.38%Maintains
3 months ago
Cvrx IncCVRX
8Strong Buy$20.00+173.22%Maintains
3 months ago
Boston Scientific CorpBSX
3Strong Buy$115.00+11.79%Maintains
3 months ago
Avita Medical IncRCEL
7Hold$12.00+23.84%Reiterates
6 months ago
Globus Medical IncGMED
6Strong Buy$100.00+39.33%Maintains
6 months ago
Stryker CorpSYK
9Strong Buy$420.00+12.32%Reiterates
6 months ago
Integer Holdings CorpITGR
2Strong Buy$140.00+10.84%Reiterates
6 months ago
Procept Biorobotics CorpPRCT
3Strong Buy$75.00+38.94%Reiterates
7 months ago
Dexcom IncDXCM
11Strong Buy$90.00+26.09%Reiterates
8 months ago
Medtronic PLCMDT
4Hold$90.00+6.18%Maintains
8 months ago
Cutera IncCUTRQ
7Hold$1.00+930.93%Reiterates
9 months ago
Paragon 28 IncFNA
4Strong Buy$12.00-8.33%Reiterates
9 months ago
Tandem Diabetes Care IncTNDM
8Strong Buy$55.00+226.41%Reiterates
9 months ago
Conmed CorpCNMD
8Strong Buy$80.00+62.90%Maintains
9 months ago
Zimmer Biomet Holdings IncZBH
13Hold$115.00+11.60%Downgrades
10 months ago
Si Bone IncSIBN
1Strong Buy$25.00N/AInitiates Coverage On
a year ago
Humacyte IncHUMA
2Hold$3.00N/AMaintains
a year ago
Apyx Medical CorpAPYX
2Strong Buy$4.50N/AMaintains
2 years ago
Miromatrix Medical IncMIRO
4Strong Buy$3.00N/AMaintains
2 years ago
Minerva Surgical IncUTRS
5Strong Buy$20.00N/AMaintains
2 years ago
Orchestra Biomed Holdings IncOBIO
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Elutia IncELUT
2Strong Buy$10.50N/AMaintains
2 years ago
Motus Gi Holdings IncMOTS
2Strong Buy$90.00N/AMaintains
2 years ago
Nuvasive IncNUVA
3Strong Buy$50.00N/AMaintains
2 years ago
Abiomed IncABMD
3Hold$380.00N/ADowngrades
3 years ago
Seaspine Holdings CorpSPNE
2Strong Buy$12.00N/AMaintains
3 years ago
Cooper Companies IncCOO
1Strong Buy$108.75N/AMaintains
4 years ago
Surgalign Holdings IncSRGAQ
1Strong Buy$120.00N/AInitiates Coverage On
4 years ago
Zynex IncZYXI
2Hold$18.18N/ADowngrades
4 years ago
Baxter International IncBAX
2Hold$80.00N/ADowngrades
4 years ago
Koru Medical Systems IncKRMD
2Hold$4.50N/ADowngrades
4 years ago
Merit Medical Systems IncMMSI
1Strong Buy$50.00N/AReiterates
5 years ago
Itamar Medical LtdITMR
1Strong Buy$22.00N/AInitiates Coverage On
5 years ago
Integra Lifesciences Holdings CorpIART
7Hold$58.00N/ADowngrades
5 years ago
Align Technology IncALGN
1Strong Buy$325.00N/AMaintains
7 years ago
Mimedx Group IncMDXG
1Strong Buy$10.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.